Azeloglycine and nicotinamide down-regulate pro-inflammatory mediators in vitro

G Ital Dermatol Venereol. 2017 Feb;152(1):90-92. doi: 10.23736/S0392-0488.16.05229-9. Epub 2016 Mar 24.

Authors

Serena Lembo¹, Roberta DI Caprio², Anna Balato¹, Anna R Bigioni³, Giuseppina Caiazzo¹, Maria Schiattarella¹, Giuseppe Monfrecola¹

Affiliations

¹ Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
² Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy - rob.dicaprio@libero.it.
³ Visufarma S.p.A, Rome, Italy.

PMID: 27013148
DOI: 10.23736/S0392-0488.16.05229-9

No abstract available

MeSH terms

Anti-Inflammatory Agents / administration & dosage
Anti-Inflammatory Agents / pharmacology
Cell Line
Down-Regulation / drug effects*
Glycine / administration & dosage
Glycine / analogs & derivatives*
Glycine / pharmacology
Humans
Inflammation Mediators / metabolism*
Niacinamide / administration & dosage
Niacinamide / pharmacology*

Substances

Anti-Inflammatory Agents
Inflammation Mediators
azeloglycine
Niacinamide
Glycine